These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 38345442)

  • 1. Transcriptional cofactor dyxin mediates hypertrophic response in the heart during angiotensin II-induced hypertension.
    Sakkinen H; Luosujarvi H; Karvonen T; Mustonen E; Moilanen AM; Aro J; Napankangas J; Ruskoaho H; Rysa J
    J Physiol Pharmacol; 2023 Dec; 74(6):. PubMed ID: 38345442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of miR-142-3p improves mitochondrial function in cardiac hypertrophy.
    Liu BL; Cheng M; Hu S; Wang S; Wang L; Tu X; Huang CX; Jiang H; Wu G
    Biomed Pharmacother; 2018 Dec; 108():1347-1356. PubMed ID: 30372837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac gene expression of natriuretic substances is altered in streptozotocin-induced diabetes during angiotensin II-induced pressure overload.
    Ruzicska E; Foldes G; Lako-Futo Z; Sarman B; Wellmann J; Szenasi G; Tulassay Z; Ruskoaho H; Toth M; Somogyi A
    J Hypertens; 2004 Jun; 22(6):1191-200. PubMed ID: 15167455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of endostatin overexpression on angiotensin II-induced cardiac hypertrophy in rats.
    Dai YJ; Gong JX; Bian R
    Chin Med J (Engl); 2019 Nov; 132(22):2716-2723. PubMed ID: 31725448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GDF11 Attenuated ANG II-Induced Hypertrophic Cardiomyopathy and Expression of ANP, BNP and Beta-MHC Through Down- Regulating CCL11 in Mice.
    Zhang C; Wang Y; Ge Z; Lin J; Liu J; Yuan X; Lin Z
    Curr Mol Med; 2018; 18(10):661-671. PubMed ID: 30714521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posttranscriptional control of BNP gene expression in angiotensin II-induced hypertension.
    Suo M; Hautala N; Földes G; Szokodi I; Tóth M; Leskinen H; Uusimaa P; Vuolteenaho O; Nemer M; Ruskoaho H
    Hypertension; 2002 Mar; 39(3):803-8. PubMed ID: 11897768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel p38 MAPK target dyxin is rapidly induced by mechanical load in the heart.
    Luosujärvi H; Aro J; Tokola H; Leskinen H; Tenhunen O; Skoumal R; Szokodi I; Ruskoaho H; Rysä J
    Blood Press; 2010 Feb; 19(1):54-63. PubMed ID: 20175653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for a functional role of angiotensin II type 2 receptor in the cardiac hypertrophic process in vivo in the rat heart.
    Lakó-Futó Z; Szokodi I; Sármán B; Földes G; Tokola H; Ilves M; Leskinen H; Vuolteenaho O; Skoumal R; deChâtel R; Ruskoaho H; Tóth M
    Circulation; 2003 Nov; 108(19):2414-22. PubMed ID: 14568903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of salusins alleviates hypertrophic cardiomyopathy via attenuating oxidative stress and autophagy.
    Dang JY; Zhang W; Chu Y; Chen JH; Ji ZL; Feng P
    Eur J Med Res; 2024 Feb; 29(1):109. PubMed ID: 38336819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of myofibrillogenesis regulator-1 aggravates cardiac hypertrophy induced by angiotensin II in mice.
    Li HL; She ZG; Li TB; Wang AB; Yang Q; Wei YS; Wang YG; Liu DP
    Hypertension; 2007 Jun; 49(6):1399-408. PubMed ID: 17420335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of natriuretic peptides and their receptors in volume overload cardiac hypertrophy in the rat.
    Su X; Brower G; Janicki JS; Chen YF; Oparil S; Dell'Italia LJ
    J Mol Cell Cardiol; 1999 Oct; 31(10):1927-36. PubMed ID: 10525429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Let-7a Is an Antihypertrophic Regulator in the Heart via Targeting Calmodulin.
    Zhou X; Sun F; Luo S; Zhao W; Yang T; Zhang G; Gao M; Lu R; Shu Y; Mu W; Zhuang Y; Ding F; Xu C; Lu Y
    Int J Biol Sci; 2017; 13(1):22-31. PubMed ID: 28123343
    [No Abstract]   [Full Text] [Related]  

  • 13. CD38 promotes angiotensin II-induced cardiac hypertrophy.
    Guan XH; Hong X; Zhao N; Liu XH; Xiao YF; Chen TT; Deng LB; Wang XL; Wang JB; Ji GJ; Fu M; Deng KY; Xin HB
    J Cell Mol Med; 2017 Aug; 21(8):1492-1502. PubMed ID: 28296029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect and mechanism of Linggui Zhugan Decoction in regulating Sig1R on AngⅡ-induced cardiomyocyte hypertrophy].
    Wang X; Mo JJ; Tang TJ; Ding R; Huang JL
    Zhongguo Zhong Yao Za Zhi; 2024 Feb; 49(3):754-762. PubMed ID: 38621879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone plays a permissive role in angiotensin II-induced hypertension and cardiac hypertrophy in male rats.
    Mishra JS; More AS; Gopalakrishnan K; Kumar S
    Biol Reprod; 2019 Jan; 100(1):139-148. PubMed ID: 30102356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adiponectin mediates cardioprotection in oxidative stress-induced cardiac myocyte remodeling.
    Essick EE; Ouchi N; Wilson RM; Ohashi K; Ghobrial J; Shibata R; Pimentel DR; Sam F
    Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H984-93. PubMed ID: 21666115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effects of Dracocephalum Heterophyllum Benth Flavonoid on Hypertrophic Cardiomyocytes Induced by Angiotensin II in Rats.
    Jiang H; Zhang C; He W
    Med Sci Monit; 2018 Sep; 24():6322-6330. PubMed ID: 30199522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of endogenous ouabain-like compound in the cardiac hypertrophic process in vivo.
    Skoumal R; Szokodi I; Aro J; Földes G; Göoz M; Seres L; Sármán B; Lakó-Futó Z; Papp L; Vuolteenaho O; Leppäluoto J; DeChâtel R; Ruskoaho H; Tóth M
    Life Sci; 2007 Mar; 80(14):1303-10. PubMed ID: 17266992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of adrenomedullin on hypertrophic responses induced by angiotensin II, endothelin-1 and phenylephrine.
    Luodonpää M; Vuolteenaho O; Eskelinen S; Ruskoaho H
    Peptides; 2001 Nov; 22(11):1859-66. PubMed ID: 11754973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of ventricular myocytes and nonmyocytes interaction during cardiocyte hypertrophy: evidence for endothelin-1 as a paracrine hypertrophic factor from cardiac nonmyocytes.
    Harada M; Itoh H; Nakagawa O; Ogawa Y; Miyamoto Y; Kuwahara K; Ogawa E; Igaki T; Yamashita J; Masuda I; Yoshimasa T; Tanaka I; Saito Y; Nakao K
    Circulation; 1997 Nov; 96(10):3737-44. PubMed ID: 9396478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.